I. INTRODUCTION
The development of biosensors based upon live, electrically active cells in culture [cell-based biosensors (CBBs)] represents the convergence of several technologies. Sensors of this type are by definition two-stage. Live biological cells serve as the primary transducers, converting the detected molecular signal into signals measured in turn via a secondary transduction means such as an extracellular electrode or optical detector. This review is restricted to the cellular signal detection using electrodes, and the interested reader is directed toward Pancrazio et al. [1] , Ziegler [2] , and McFadden [3] for more general overviews. It is also noteworthy that electronic detection using insulated-gate FET devices (as demonstrated by Fromherz et al. [4] , [5] ), impedance methods [6] - [10] , extracellular pH measurements [11] - [15] , and micromachined "patch-clamp" devices [16] are beyond the scope of this paper, but quite relevant to the overall scheme of CBBs. In a general sense, cell-based sensors are useful because they harness highly evolved cellular pathways. As opposed to sensors based on specific molecular detection (such as those using enzyme reactions [17] , binding of antibodies [1] , [17] - [19] , or hybridization of nucleic acids [20] ), cellular responses are physiologic and allow the detection of unanticipated threat agents (hence without need for predetermined and fabricated immunoglobulins or DNA probes). In addition, and importantly, they can be used to study the potentially complex cellular effects of mixtures of compounds. These properties make such sensors highly attractive for detection of chemical and biological toxins, environmental toxins, and for the screening of pharmaceuticals. Unlike many of the alternatives mentioned previously, however, the sensitivities of cell-based sensors to biological toxins and chemical agents depend upon the type of cells used and the nature of the agents.
It is important to note that one cannot directly compare CBBs to the extremely high-gain approaches such as the polymerase chain reaction (PCR) for DNA [20] - [23] . With PCR, one might be able to find minute traces of DNA from biological production of a toxin, but not measure the actual toxin concentration in a sample. The two techniques may well be used together, since unknowns to be detected may include infectious agents, for which PCR is well suited if the specific diagnostic reagents for each organism are available in advance. The ability of cell-based sensors to detect new toxins without advance preparation suggests that they will play a very useful and complementary role to assays based on molecular recognition.
II. ELECTRONIC COUPLING TO CELLULAR SIGNALS
The recording of extracellular action potentials (APs) is well established [24] , as is the culture of a variety of cell types that spontaneously generate action potentials that can be recorded successfully [25] - [27] . The basic interface between the cells and external electronics consists of conductive microelectrodes created by exposing small regions of thin-film conductors beneath an insulating top layer. Fig. 1 shows a typical microelectrode in cross section. In this case, a glass substrate was used, but as can be seen from the prior work referenced herein, a variety of biocompatible substrates are suitable, such as silicon (potentially including active electronic circuits), plastics, ceramics, etc.
As discussed in several prior publications [24] , [28] - [30] , an equivalent circuit suitably represents the microelectrode as a recording interface, with the addition of a parallel nonlinearity when the electrodes are driven for use in stimulation. Tight coupling of an overlying cell to the electrode will increase the detected AP signal amplitude, as will decreasing the impedance of the electrode (and thereby its thermal noise contribution) [24] , [30] . Although different physical designs have been demonstrated beyond simple planar electrodes, including structures to enhance cell-to-electrode coupling (e.g., [31] ), the basic concepts remain the same.
The signal source, action potentials originating at the cell itself, are caused by gated ionic currents traversing the cell membranes. While the specifics are different for neural versus cardiac cells, the basic concepts are comparable. The reader is directed to one or more of the literature references discussing the underlying mechanisms [32] - [34] . Fig. 2 illustrates the relationship of the intracellular signal and what is actually measured using extracellular electrodes. The movement of ions in the extracellular solution creates potentials that can be detected using a closely spaced electrode relative to a more distant reference electrode. Depending upon cell type, the signal amplitudes seen range from tens of microvolts through several millivolts, with bandwidths generally between a few hundred hertz and one kilohertz. For neurons, signals tend to be on the lower end of the amplitude range. Cardiac cells typically interconnect via cellular gap junctions (effectively resistive couplings) and generate APs in the form of propagating depolarization fronts of considerably larger amplitudes (such a coupled layer of cells is referred to as a syncitium). Example myocardial AP signals are shown in Fig. 3 . In either case, since the signals are coupled through the electrode capacitance and also since the transmembrane current sources active at a given instant are moving relative to the electrode, the recorded waveforms are essentially second time derivatives of the intracellular potential [24] , [34] , [35] . This relationship can be seen in Fig. 2 , but in practice may span a continuum from first through third derivative depending upon how well coupled a cell is to an electrode [34] , [35] .
As mentioned previously, the ability to record APs from individual cells requires microelectrodes comparable in size to the cells themselves. This calls for electrode dimensions on the order of tens of micrometers or smaller unless the cells are interlinked as in a myocardial syncitium. Electrodes much larger than cells will not yield recordable signals due to decreasing "seal" impedance (voltage division of the signal), whereas electrodes that are too small will have electrical outputs dominated by Johnson noise of the electrode impedance's real component [29] , [30] .
The ability to produce micrometer-scale electrodes was an offshoot of the explosive growth of IC technology in the 1960s. A wide variety of lithographic, thin-film deposition, etching, and other tools soon became available. These tools were initially used to make digital logic and analog ICs, but soon were harnessed to fabricate a variety of mechanical, chemical, and optical sensors [36] , [37] . During this period, researchers began exploring the microfabrication of electrodes for recording APs from neurons. Wise et al. [38] , Starr et al. [39] , and Wise and Angell [40] demonstrated needlelike silicon probes with on-board microelectrodes that were used to record signals from the brains of intact animals. Similarly, work began on cell-and tissue-culture substrates equipped with such electrodes, with the earliest work appearing to be that of Thomas et al. [41] . They demonstrated AP recordings from dissociated chick myocardial cells. In 1974, Shtark et al. [42] demonstrated the first recordings from neuronal (rat brain) cells on such an array. Neuronal signals from snail ganglia were demonstrated by Gross et al. [43] , [44] using snail ganglia, and from dissociated rat cervical ganglia by Pine [45] . A wide variety of cell types and microelectrode designs were subsequently demonstrated [46] - [50] . For more detailed surveys, the reader is referred to Stenger and McKenna [51] and Pancrazio et al. [1] .
Deliberate stimulation of APs has also been demonstrated in dissociated chick cardiac cells by Israel et al. [52] , [53] and Connolly et al. [35] , Heliosoma (snail) neurons by Regehr et al. [31] , mouse and chick dorsal root ganglion cells by Jimbo and Kawana [54] , [55] , and hamster spinal cord slices by Borkholder et al. [56] . These techniques have not yet been broadly applied to CBBs, but can readily be employed using the same microelectrode arrays used for AP recording.
An additional noteworthy area of research has been that of patterning of the cultured cells relative to the microelectrodes using a variety of methods such as physical or surface chemical [57] - [60] . It should be noted, however, that for the sensor applications described later, these methods have thus far only succeeded for relatively short periods (days to perhaps weeks) and do not appear to be critical to the realization of practical CBBs.
While it is thus clear that much the background literature on this subject dates back several decades, it was only more recently that researchers began exploring the development of realistic sensors using these approaches. With basic science driving the initial efforts, it was realized that such devices had the potential to act as broad-spectrum detectors and screening tools. Gross et al., published some of the earliest laboratory work with this clearly in mind [61] , [62] and continued development of such sensors [63] . (It is noteworthy that Keese and Giaever [10] carried out early work with the same goals, but using impedance rather than action potential methods.) Subsequent interest in detectors for chemical and biological warfare agents spurred the development of fieldable instrumentation based on this principle [64] - [66] , as discussed later.
III. CELLULAR ELEMENTS
The preceding discussion presented the basics of operation of cell-based sensors. The underlying transducer platform-an array of microelectrodes-is for the most part identical for any cell types used. However, the major determinant of sensor function, reproducibility, and sensitivity is the choice of the primary transduction element-the cultured cells themselves.
To date, work on electrical detection methods has focused on neuronal and cardiac cell types since they are primary targets of compounds of interest and because they naturally support microelectrode interfaces through their anchorage dependent nature. Within the scope of this review, the candidate cells discussed generate spontaneous action potentials (or, potentially, generate them in response to a "pacing" stimulus). As mentioned previously, other methods such as impedance measurements can be used with nonelectrically active cell types, as can optical detection and indirect (chemical) metabolic sensing.
Regardless of a cell type's organ-specific origins, one can employ primary (derived from fetal or adult animals) cells or immortalized cell lines [26] , [27] , [67] . The latter are not subject to the Hayflick limit [68] (although older cultures can show marked changes in characteristics), which determines the maximum number of times a cell can divide prior to death, as are tissues we think of as "normal" (in fact, cell lines are akin to or derived from cancers). The potential benefits of using immortalized lines include the ability to avoid the use of animals, the possibility of more consistent cultures, and the potential to utilize various methods of genetic engineering that are difficult with primary cells [21] , [27] , [67] . However, genetically engineered primary cells have been demonstrated in CBBs [69] .
Primary cells generally are not of a single genetic makeup (an important property of cell lines) but are more likely to closely represent normal cell targets. Also, primary neurons can organize themselves more readily into functional networks of cells with complex behaviors similar to those in an intact organism. At this time, the bulk of the work on cell-based sensors has been done with primary cells, but considerable exploration is under way to utilize cell lines for such sensors. The search for suitable neuronal cell lines has yet to yield candidates with strong, reproducible action potentials recordable with microelectrodes, but a useful murine (mouse), atrial-derived cardiac cell line, HL-1 cells has been developed [70] .
For neurons, a wide variety of tissues have been used as the source material. The bulk of the sensor work to date has been done using dissociated primary neurons. Such cultured cells form spontaneously active networks, from which fairly complex behaviors such as bursting and oscillation emerge (a typical dissociated neuron culture atop a microelectrode array is shown in Fig. 4 ). These patterns of activity can provide subtle or dramatic indications of physiologic actions of external agents. As reviewed in Pancrazio et al. [1] , dissociated neurons from a variety of invertebrate and mammalian sources have been used successfully. Tissue slices seem less likely to be applied in practical sensors due to the complexity of preparing them and the difficulty in maintaining stable coupling to the electrodes with movement of the sensor.
Successful demonstrations of cardiac-cell CBBs have utilized chick [35] , [52] , [53] , [64] and mouse primary myocardial cells [69] , and the mouse-derived HL-1 atrial cell line [65] , [66] . As mentioned previously, dissociated myocardial cells generally form contiguous, physically and electrically connected sheets-syncitia-over the electrodes. Fig. 5 shows such a sheet of HL-1 cells cultured atop a CMOS microelectrode array. The gap junctions that form between the cells allow them to synchronize their activity, resulting in waves of depolarization (and physical contraction) that propagate across the electrode array. While the mechanical movement of the cells can potentially introduce signal artifacts not seen with neurons, the generally synchronous behavior of the cardiac cells produces compound action potentials with larger amplitudes (neuronal APs derive from individual cells).
It is worth noting that there are other cell types that could potentially produce spontaneous APs. Specifically, neuroendocrine cells, such as pancreatic islet cells are known to exhibit such behavior [71] , [72] , but have yet to yield successful AP recordings in microelectrode-based biosensors.
As mentioned previously, it is possible to genetically engineer the cells to obtain highly specific response capabilities. For example, it is possible to knock out (remove) genes that code for certain receptors, as long as their absence is not lethal to the organism or cell. With this approach, dual cell-based sensors, one with the knockout cells and one with normal, or wild-type, cells can be used, and differences in response to a test agent applied to both can be attributed to the specific receptor that has been removed. Aravanis et al. [69] demonstrated this approach using primary mouse cells in which the -adrenergic receptors had been knocked out, and showed that they could obtain a truly differential response between knockout and wild-type cell populations on electrode arrays. This approach may prove particularly useful for the screening and testing of pharmaceutical agents, and can be scaled up to diverse arrays of engineered cells to be compared to a wild-type population.
While both neuronal and cardiac cell types may prove to have significant overlaps in terms of the types of agents they can detect, it is likely that having the complementary cell types will provide a superior overall capability. In fact, since culture conditions for mammalian (for example) tissues tend to be fairly uniform, considerable cell-type diversity is possible within CBB systems, allowing parallel screening of unknowns using several tissue types in separate culture wells.
For some applications (such as lengthy sensor deployments in military settings), longevity of the cultured cells on a scale of weeks or even months is of great importance. With appropriate choices of cells and methods, this is achievable [73] . For pharmaceutical screening applications, only a day or two of operational lifetime may be adequate. However, for both applications, it may be desirable to prepare CBB substrates with cells in advance and place them into a storage or "hibernation" state, with procedures available for rapidly preparing them for use. This approach has been demonstrated for both neuronal [74] and cardiac cells [75] , and could likely be broadly applied for CBBs. Fig. 6 shows results of a hibernation experiment using the HL-1 myocardial cell line, wherein the media change requirement was reduced from daily to weekly changes.
As discussed later, the primary source of inconsistency between cell-based sensors of any type is variation in the cellular components. For primary cells, variations in genetics between source animals and even differences in dissection techniques can create such variations. For cell lines, despite the promise of more uniform cultures at the expense of some differences from wild-type cells, significant variation in batch-to-batch and sensor-to-sensor performance is often seen (but rarely published). To date, a detailed study has not been carried out to compare the variations between primary and immortalized cell types, nor have sufficient resources yet been applied to improving the net yield from the viewpoint of controlling the biological processes.
IV. SIGNAL ANALYSIS AND INTERPRETATION
As mentioned previously, early work with cultured cells and tissues on microelectrode arrays focused on basic science goals. Initially, simply obtaining a believable AP recording was an achievement in itself. As the field matured, this became routine, and some researchers turned their attention toward developing practical sensors based on the technology. To date, several demonstrations indicate that this can be done, with a fair number of compounds proven to be detectable over useful concentration ranges (for example, [63] ). In order to develop robust CBBs for general use and for unknown agents, it is necessary to demonstrate reproducible sensors with statistically defined sensitivities (both in terms of which agents they respond to, but also what concentration ranges they can detect). A further complication is that realistic samples may contain a number of different agents and interfering chemicals.
In comparison to molecular detection methods, current cell-based sensors are much more variable in their nature. Not only is the physical coupling of cells to electrodes different on a case-by-case basis, but variations from batch-to-batch, chip-to-chip, and electrode-to-electrode can be significant. Thus, robust signal analysis algorithms are needed, hopefully which can deliver useful and relatively consistent sensor responses in the face of biological variation. Rather than providing some sort of absolute calibration prior to use, as is common with most chemical sensors, methods for using CBBs tend to be based on relative changes with respect to a locally established baseline. Further, it is ultimately necessary for most sensor applications to output clear, numerical responses or even "red-light/green-light" binary outputs based on well-defined relative thresholds. This must be done automatically if sensors are to be used by nonspecialist personnel or in high-throughput situations such as pharmaceutical screening.
In practice, algorithms fall into two categories, with increasing complexity. First, and most simply, detection algorithms respond to statistically significant changes in some property or properties of AP signal behavior across one or more electrodes. Since such changes are often seen via simple metrics such as rate changes up or down, one can begin to classify compounds as excitatory or inhibitory on such a basis. For the example of pyrolysis products of synthetic ester turbine engine lubricants known to cause neurologic problems, Keefer et al. [76] showed in a blinded experiment that it is possible to predict the physiologic manifestations using CBBs consistently with animal exposures. Full classification, however, would entail something more akin to comparing multiparameter fingerprints (some direct, such as rate, and others computed, such as dose/response relationships with straight and diluted samples) against stored calibrations. In a practical system, it is likely that potentially matching compounds would be indicated to a user ranked by probability [77] . Again, since the biological components of CBBs can be variable, such algorithms represent significant challenges. Another approach to classification involves so-called "challenge assays," in which known competitive or "antidote" compounds are added to the CBB mixed with the unknown (in addition to controls: unknown alone and competitive compound alone), potentially providing useful information about the nature of the unknown.
A variety of algorithmic approaches have been explored, and work in this area is ongoing. For both cell types, counting AP rates over time is a starting point. More subtle time-domain measures, such as interspike phase, computed conduction velocity using multiple electrodes apply primarily to cardiac tissues, while burst patterns, rates, and more complex signal relationships are more relevant to neural signals. Frequency domain approaches are also promising, and are based on the observation that the morphology of the recorded APs can change significantly when agents act on the cells [78] . Naturally, time-domain morphologic change measures can also be used [79] , such as waveform templating (approximation of matched filtering), thresholding (oscilloscope-like triggering), and more complex approaches such as wavelet analysis [80] . It is likely that parallel combinations of algorithms-perhaps different ones for different classes of agents-will be required to obtain optimal detection and classification. It should be noted that counted parameters such as AP and burst rates have accuracies directly proportional to the length of time over which they are acquired, and nontemporal methods have the potential to provide much more rapid results if sufficiently high signal-to-noise ratios (SNRs) are possible.
In any such CBB system, the first step in analyzing the signals is electrode selection, which is carried out to limit data collection and analysis to those electrode sites producing signals of suitable form and SNR. An example approach is illustrated in Fig. 7 , showing a manual selection process based on waveform inspection. An example automated electrodeselection approach based on direct SNR measurement is described in [66] . In any case, one needs sufficient numbers of useable electrodes per array to maintain statistical validity of any detection/classification algorithms. It is noteworthy that this issue is far from having been dealt with fully for either neural nor cardiac CBBs.
For neuron-based sensors, the typical approach to detection algorithms is to use time-domain methods. As an example, the method employed by Gross et al. [82] - [85] using networks of dissociated mouse spinal neurons is to compute, on a minute-to-minute basis, the following param- eters (for each electrode): 1) spike number; 2) burst number; 3) mean burst duration; 4) mean integrated burst amplitude; and 5) mean burst period. These minute parameters are averaged over the entire neuronal network to obtain the global equivalents, as shown in the example in Fig. 8 . To establish a statistical baseline for a network that has not been exposed to any agents, these parameters are averaged over several minutes to obtain a reference mean and standard deviation. Detection is thereafter indicated by events that cause one or more parameters to exceed the standard deviation in either direction. As agent concentrations are varied, the parameters are logged, and can be used to derive a dose/response curve. Classification can be carried out based on the temporal dynamics of the parameters, allowing the effects to be categorized as excitatory, inhibitory, or disinhibitory. In addition, other parameters can be considered such as delay times, activity decay slopes, systematic changes in burst variables, and reversibility versus irreversibility.
For cardiac cells, the general approach is similar, but much more inclusive of AP morphology and phase changes as output parameters. In addition, since a syncitium is formed, it is possible to evaluate propagation ("conduction") velocity, which can be a sensitive indicator of cellular damage. As illustrated in Fig. 9 , a variety of parameters can be computed in parallel (real-time) and used to generate population means and standard deviations. As described previously, changes in these parameters can be used to categorize the nature of the detected agent. If various known concentrations can be applied, dose-response curves can be derived [65] , as shown in Fig. 10 .
V. APPLICATION DOMAINS
With practical cell-based sensors on the horizon, it is important to consider the necessary supporting technologies that allow their adaptation to specific application domains. The primary drivers for their development are the need to sense chemical and biological toxins in air and water, and the desire to bring relatively high throughput physiologicfunction-based screening to the pharmaceutical marketplace. While both ultimately represent significant markets, the potential volume in the latter makes it an attractive entry and focal point for commercial development.
A. Fieldable Systems
To realize field-portable detectors for chemical and biological agents, considerable changes must be made relative to the equipment used in typical laboratory-based situations. First, the entire system must be robust, relatively compact, and able to source or self-power for a reasonable operational period. Second, the cells must be packaged in such a way as to maintain sterility and proper environmental conditions for culture, yet allow the introduction of unknown agents. Typically, the cells, microelectrode arrays, and potentially some fluidic interfaces are combined into a user-replaceable cartridge. The cells must also be maintained at constant pH, osmolarity, and temperature, typically via chemical buffering, humidification, and closed-loop thermal control, respectively [65] , [66] , [86] . The high sensitivities of cells to changes in these parameters can lead to false "signals" if they are not tightly controlled. In addition, sample preparation, which is typically done manually in the laboratory, must be automated so that it is capable of being carried out in realistic environmental conditions.
Beginning with the first such work presented in Pancrazio et al. [64] , there has been steady progress toward realizing such practical, field-portable systems with the advent of a DARPA program in the area. Gilchrist et al. [65] demonstrated a field-portable incubator and CBB data recording system in field tests that included ground and air transportation and were able to acquire and pharmacologically modulate AP signals in a desert setting (see Fig. 11 ). A hand-held recording system with integrated cell cartridges incorporating closed-loop thermal control and front-end amplification and multiplexing electronics was also demonstrated [66] , as shown in Fig. 12 . For cell types that require temperature regulation, shrinking the controlled The recording system used a laptop computer to capture data for later analysis, which currently can be done in real-time. Both systems were tested in realistic field conditions [65] . Courtesy of V. Barker (a) and K. Gilchrist (b), both of Stanford University, Stanford, CA.
Fig. 12.
Prototype hand-held CBB instrument [66] . At lower left, the disposable cartridge can be seen. It contains a CMOS-based microelectrode array die and has two independent cell culture wells (one for the unknown and one to serve as a control). Courtesy of B. DeBusschere, Stanford University, Stanford, CA.
volume has definite advantages in terms of power consumption and hence weight and volume.
More recent work has addressed the need for automated sample preparation. For practical application in military and first-responder situations, cumbersome measurement, titration, and other steps must be carried out without significant user intervention. Basic requirements for CBB sample handling include filtration, balancing of pH and osmolarity, mixing with appropriate cell culture media, and warming to the culture's nominal operating temperature. Fig. 13 is a photograph of such a system, which processes water-based samples (from potential drinking water sources or air samplers with aqueous outputs) for application to CBBs.
For such sensors, longevity of the cellular components could be a limiting factor, depending upon operational expectations. As noted previously, dissociated primary neuron cultures have been maintained on electrode arrays for many months. Primary and immortalized cardiac cells tend to offer on-chip operational lifetimes on the order of a week, but can be metabolically slowed greatly using special culture media and revived when needed [75] (similar "hibernation" media have been demonstrated with neuronal cells [74] ).
Ultimately, it is likely that CBB systems will be fully integrated, with end-to-end processing, analysis, archiving, and display integrated into a single unit. A mature fieldable system would be rugged, compact, transportable, and capable of long standby times between uses. In addition, the user interface would require considerable development beyond current prototypes, such that an appropriate level of information was made available to the user, and with extremely high reliability and accuracy.
B. Pharmaceutical Screening
The requirements for pharmaceutical screening systems based on CBBs are naturally very different from those for military and civil defense functions. In the former case, moderate-to-high throughput of parallel samples is required, with a high degree of automation and a full suite of data interpretation and management tools. Typical formats for (a) (b) Fig. 13 . Photographs of a prototype sample preparation system for CBB applications. In (a), the entire system is shown in a top view. In (b), the sample processing module is raised to its operational position and the sample cup can be seen. This system filters particulates from the sample and then automatically measures and adjusts its pH, osmolarity, and temperature. Courtesy of V. Barker, Stanford University, Stanford, CA. molecular screens are 96-and 384-well plates, and such formats should be achievable with CBB technologies. Robotic systems for handling the dispensing of fluids and movement of such plates are commercially available, as are databases and archiving tools (useful review articles include [87] - [89] ). The massive parallelism possible with such an approach would allow not only for rapid screening of the vast compound libraries pharmaceutical companies possess, but also allow matrix experiments to examine dose/response behavior and drug synergies, for example.
In order to realize such systems, one would need to develop low-cost, highly parallel cartridges for use in culturing the cells and in the screening experiments themselves. As currently envisioned, such a cartridge would consist of a low-cost electrode substrate, a plastic well-forming plate, and potentially a removable lid. If one were using cardiac cells, with synchronous beating in each well, a fairly small number of electrodes per well would be required, with a somewhat higher number if networks of cultured neurons were used in order to guarantee an acceptable yield of "usable" sites. Assuming a few electrodes for each well of a 96-well cartridge, some form of electronic multiplexing will almost certainly be required. This could be achieved at a reasonable cost for a disposable cartridge. In this application, cell longevity may not be a significant issue, and local cell culture capability is typical in laboratories engaged in pharmaceutical research.
It seems quite possible to not only meet the physical and electronic requirements for such a system, but with the addition of reproducible cell cultures and computationally optimized algorithms, high-throughput operation appears realistic in the near future.
VI. DISCUSSION
This review has presented an overview of background and current issues in the development of practical, cell-based sensors for biologically active compounds. By harnessing the natural physiologic pathways of live cells, these devices offer the potential for broad-spectrum detection of chemical and biological warfare agents, naturally occurring environmental toxins, and potentially beneficial pharmaceuticals in screening applications.
Research in this field to date has been encouraging, yet there are several significant barriers to commercialization and more widespread use. First, for all systems demonstrated to date (based on primary cells or lines), variability between batches, chips, and electrodes is relatively large. Although not well documented in the literature, this issue still requires considerable effort, and is tied into the nature of the cells used.
While biocompatible materials are commonplace and relatively simple to screen for, cell culture techniques tend to be fairly empirical, and, if serum-containing media are used, depend on pooled animal products and their potential variations. Surfaces upon which cells are plated may also have a wide range of effects, although far easier to standardize. In all of these cases, results may be cell-type specific and, making matters worse, exact details are seldom published. However, successes to date suggest that even with a lessthan-perfect yield, successful single-shot (fieldable) and parallel cell-based screening tools could be realized.
Another vital requirement for such systems (from which military systems are not entirely exempt) is that of a practical and profitable business model to spur development into realistic products. While beyond the scope of this review, this factor must be considered as it can be even more critical than technology capability in terms of what ultimately reaches end-users.
Overall, the vast potential of this approach will likely drive wider adoption. Key in this process are the abilities to scale up to parallel, high-throughput systems, to develop better and better signal interpretation algorithms, and to engineer the primary transducer-the cell-to provide otherwise unavailable capabilities.
